We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Single Dose Antibody Therapy in Newborns Could Thwart HIV

News   Jan 08, 2020 | Original story from Oregon Health & Science University.

 
Single Dose Antibody Therapy in Newborns Could Thwart HIV

Researchers at OHSU have found a single dose of antibodies given 30 hours after exposure to SHIV, the monkey form of HIV, prevented newborn rhesus macaques (shown here) from becoming infected. The finding could provide a new way to prevent human newborns from becoming infected with HIV after they are born from HIV-positive mothers. Credit: OHSU/William Sutton.

 
 
 

RELATED ARTICLES

"Unhealthy" Gut Microbiome Linked to PCOS and Obesity in Teens

News

New research has found that teens with obesity and polycystic ovary syndrome (PCOS) have more “unhealthy” gut bacteria which, according to the study, suggests the microbiome may play a role in the disorder.

READ MORE

Novel Cellular Entry Factor for Viral Vectors Used in Gene Therapy

News

Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types--the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors-or vehicles--that are created from a virus that is made harmless by molecular engineering, and have shown promise transporting genetic therapy treatments to affected tissues.

READ MORE

Vaccine for African Swine Fever Virus Shows Promise

News

Government and academic investigators have developed a vaccine against African swine fever that appears to be far more effective than previously developed vaccines.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE